EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over longer horizons, EBITDA CAGR averages 5.60% over 3 years and 4.61% over 5 years; the trailing 12 months came in at +7.48%. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
ABT EBITDA CAGR Chart
Abbott Laboratories (ABT)
tgmcharts.com
ABT Quarterly EBITDA Growth (YoY)
EBITDA growth vs the same quarter one year earlier, last 40 quarters.
tgmcharts.com
EBITDA
ABT Quarterly EBITDA
$2.79B
Reported quarterly EBITDA; no daily interpolation.